These factors increase the likelihood of complications such as falls, pressure sores, joint contractures, and muscle weakness
[DOI] [PubMed] [Google Scholar] 91.Kode A., Rajendrasozhan S., Caito S., Yang S.R., Megson I.L., Rahman I
Even after approval, manufacturing ramp-up and commercial launch logistics mean CagriSema likely will not be widely available to patients until the following year
received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma